Literature DB >> 33634997

The autoregulatory serglycin/CD44 axis drives stemness-like phenotypes in TNBC in a β-catenin-dependent manner.

Li Cao1, Fei-Fei Luo2, Hong-Bin Huang3, Tie-Jun Huang4, Hao Hu5, Li-Sheng Zheng2, Jing Wang2, Li-Xia Peng2, Chao-Nan Qian2,6,7, Bi-Jun Huang2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33634997      PMCID： PMC7851355          DOI： 10.1002/ctm2.311

Source DB:  PubMed          Journal:  Clin Transl Med        ISSN： 2001-1326


× No keyword cloud information.
  8 in total

1.  Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: gene amplification does not contribute to EGFR expression.

Authors:  Shinobu Umemura; Susumu Takekoshi; Yasuhiro Suzuki; Yuki Saitoh; Yutaka Tokuda; R Yoshiyuki Osamura
Journal:  Oncol Rep       Date:  2005-08       Impact factor: 3.906

Review 2.  CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?

Authors:  Margot Zöller
Journal:  Nat Rev Cancer       Date:  2011-03-10       Impact factor: 60.716

Review 3.  Breast cancer stem cells: Multiple capacities in tumor metastasis.

Authors:  Shao-Qing Geng; Aris T Alexandrou; Jian Jian Li
Journal:  Cancer Lett       Date:  2014-04-12       Impact factor: 8.679

4.  Mutation of GATA3 in human breast tumors.

Authors:  Jerry Usary; Victor Llaca; Gamze Karaca; Shafaq Presswala; Mehmet Karaca; Xiaping He; Anita Langerød; Rolf Kåresen; Daniel S Oh; Lynn G Dressler; Per E Lønning; Robert L Strausberg; Stephen Chanock; Anne-Lise Børresen-Dale; Charles M Perou
Journal:  Oncogene       Date:  2004-10-07       Impact factor: 9.867

5.  Triple negative breast cancer - prognostic factors and survival.

Authors:  Tanja Ovcaricek; Snjezana Grazio Frkovic; Erika Matos; Barbara Mozina; Simona Borstnar
Journal:  Radiol Oncol       Date:  2010-12-31       Impact factor: 2.991

6.  Serglycin is implicated in the promotion of aggressive phenotype of breast cancer cells.

Authors:  Angeliki Korpetinou; Spyros S Skandalis; Aristidis Moustakas; Kaisa E Happonen; Heidi Tveit; Kristian Prydz; Vassiliki T Labropoulou; Efstathia Giannopoulou; Haralambos P Kalofonos; Anna M Blom; Nikos K Karamanos; Achilleas D Theocharis
Journal:  PLoS One       Date:  2013-10-31       Impact factor: 3.240

7.  Extracellular serglycin upregulates the CD44 receptor in an autocrine manner to maintain self-renewal in nasopharyngeal carcinoma cells by reciprocally activating the MAPK/β-catenin axis.

Authors:  Qiaoqiao Chu; Hongbing Huang; Tiejun Huang; Li Cao; Lixia Peng; Simei Shi; Lisheng Zheng; Liang Xu; Shijun Zhang; Jialing Huang; Xinjian Li; Chaonan Qian; Bijun Huang
Journal:  Cell Death Dis       Date:  2016-11-03       Impact factor: 8.469

8.  SRGN-TGFβ2 regulatory loop confers invasion and metastasis in triple-negative breast cancer.

Authors:  Z Zhang; Y Deng; G Zheng; X Jia; Y Xiong; K Luo; Q Qiu; Ni Qiu; J Yin; M Lu; H Liu; Y Gu; Z He
Journal:  Oncogenesis       Date:  2017-07-10       Impact factor: 7.485
  8 in total
  2 in total

Review 1.  Mechanisms of Cell Adhesion Molecules in Endocrine-Related Cancers: A Concise Outlook.

Authors:  Yongsheng Ruan; Libai Chen; Danfeng Xie; Tingting Luo; Yiqi Xu; Tao Ye; Xiaona Chen; Xiaoqin Feng; Xuedong Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-07       Impact factor: 6.055

2.  Serglycin Is Involved in TGF-β Induced Epithelial-Mesenchymal Transition and Is Highly Expressed by Immune Cells in Breast Cancer Tissue.

Authors:  Marta Tellez-Gabriel; Xavier Tekpli; Trine M Reine; Beate Hegge; Stephanie R Nielsen; Meng Chen; Line Moi; Lisa Svartdal Normann; Lill-Tove R Busund; George A Calin; Gunhild M Mælandsmo; Maria Perander; Achilleas D Theocharis; Svein O Kolset; Erik Knutsen
Journal:  Front Oncol       Date:  2022-04-14       Impact factor: 5.738
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.